John A. Butera - Clarskburg NJ Craig E. Caufield - New York NY Russell F. Graceffa - Hampton NH Alexander Greenfield - Princeton Junction NJ Eric G. Gundersen - Plainsboro NJ Lisa Marie Havran - Bordentown NJ Alan H. Katz - Lawrenceville NJ Joseph R. Lennox - Morrixville NC Scott C. Mayer - Robbinsville NJ Robert E. McDevitt - Somerset NJ
This invention provides compounds of Formula I having the structure wherein: B, C, D, and R are as defined hereinbefore in the specification, or a pharmaceutically acceptable salt thereof, which are useful in treating metabolic disorders related to insulin resistance or hyperglycemia.
2,3,5-Substituted Biphenyls Useful In The Treatment Of Insulin Resistance And Hyperglycemia
John A. Butera - Clarkburg NJ Craig E. Caufield - New York NY Russell F. Graceffa - Hampton NH Alexander Greenfield - Princeton Junction NJ Eric G. Gundersen - Plainsboro NJ Lisa Marie Havran - Bordentown NJ Alan H. Katz - Lawrenceville NJ Joseph R. Lennox - Morrisville NC Scott C. Mayer - Robbinsville NJ Robert E. McDevitt - Somerset NJ
John A. Butera - Clarksburg NJ, US Craig E. Caufield - New York NY, US Russell F. Graceffa - Hampton NH, US Alexander Greenfield - Princeton Junction NJ, US Eric G. Gundersen - Plainsboro NJ, US Lisa Marie Havran - Bordentown NJ, US Alan H. Katz - Lawrenceville NJ, US Joseph R. Lennox - Morrisville NC, US Scott C. Mayer - Robbinsville NJ, US Robert E. McDevitt - Somerset NJ, US
This invention provides compounds of Formula I having the structure or a pharmaceutically acceptable salt thereof, which are useful in treating metabolic disorders related to insulin resistance or hyperglycemia.
Paul Jeffrey Dollings - Newtown PA, US Arlene Joan Dietrich - Delran NJ, US Lisa Marie Havran - Florence NJ, US Donna Mary Huryn - Allentown NJ, US Albert Jean Robichaud - Ringoes NJ, US Boyd Lynn Harrison - Princeton Junction NJ, US Wayne Everett Childers - New Hope PA, US Alexander A. Greenfield - West Windsor NJ, US James Jacob Bicksler - Titusville NJ, US Vasilios Marathias - Pennington NJ, US
Novel pyrimidoindolone compounds are disclosed. Methods of using the pyrimidoindolone compounds and compositions containing the compounds in the treatment and/or prevention of disease and other conditions related to inflammation, neurodegeneration, osteoarthritis and apoptosis are also disclosed.
Lisa Marie Havran - Florence NJ, US John Anthony Butera - Clarksburg NJ, US Hassan Mahmoud Elokdah - Yardley PA, US Douglas John Jenkins - Collegeville PA, US Eric Gould Gundersen - Royersford PA, US
Lisa Marie Havran - Florence NJ, US John Anthony Butera - Clarksburg NJ, US Hassan Mahmoud Elokdah - Yardley PA, US Douglas John Jenkins - Collegeville PA, US Eric Gould Gundersen - Royersford PA, US
Assignee:
Wyeth - Madison NJ
International Classification:
C07C 63/06 A61K 31/19
US Classification:
562440, 514568, 514570
Abstract:
The present invention relates to substituted aryl oximes and methods of using them.
Piperazine-Piperidine Antagonists And Agonists Of The 5-Ht Receptor
Magda Asselin - Mahwah NJ, US George Theodore Grosu - Pearl River NY, US Annmarie Louise Sabb - Pennington NJ, US Wayne Everett Childers - New Hope PA, US Lisa Marie Havran - Florence NJ, US Zhongqi Shen - Plainsboro NJ, US James Jacob Bicksler - Titusville NJ, US Dan Chaekoo Chong - Plainsboro NJ, US
The present invention relates to novel piperazine-piperidine compounds. The compounds are useful as 5-HT1A binding agents, particularly as 5-HT1A receptor antagonists and agonists. These compounds are useful in treating central nervous system disorders, such as cognition disorders, anxiety disorders, depression and sexual dysfunction. The invention relates to compounds and pharmaceutically acceptable salts of formula (I′):.
Lisa Havran - Florence NJ, US John Butera - Clarksburg NJ, US Hassan Elokdah - Yardley PA, US Douglas Jenkins - Collegeville PA, US Eric Gundersen - Rogersford PA, US
Assignee:
WYETH - Madison NJ
International Classification:
A61K031/343 C07D307/78
US Classification:
514469000, 549467000
Abstract:
The present invention relates to substituted benzofuran oximes and methods of using them.